BUY Aarti Drugs Limited — Axis Securities
byAxis SecuritiesHorizon: NA (inferred 1 year)11 Nov 2025via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Long-term trend bearish — 200-day average falling over the past quarter
Technicals · trend·23 Oct · 2d ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Aarti Drugs
- BUY — Axis Securities11 Oct 2026 · ~1 year · target ₹454 · Active
- BUY — Somil Mehta, Sharekhan24 Sept 2026 · ~2 weeks · target ₹550 · Expired
- BUY — Siddharth Rai Mangala1 Sept 2026 · ~2 weeks · target ₹445 · Expired
- BUY — Sahi Research24 Aug 2026 · ~2 weeks · target ₹438 · SL hit
- BUY — Axis Securities19 Aug 2026 · ~1 year · target ₹515 · Active
More from Axis Securities
- BUY Eternal22 Oct 2026 · ~1 year · target ₹390 · Active
- BUY CREDITACCESS GRAMEEN22 Oct 2026 · ~1 year · target ₹1,405 · Active
- BUY CCL Products (India)19 Oct 2026 · ~1 year · target ₹1,255 · Active
- BUY Federal Bank19 Oct 2026 · ~1 year · target ₹405 · Active
- BUY LTM19 Oct 2026 · ~1 year · target ₹4,960 · Active

